Keywords: عوارض جانبی مرتبط با ایمنی; cancer; immune-related adverse event; immunotherapy; primary care; toxicities;
مقالات ISI عوارض جانبی مرتبط با ایمنی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: عوارض جانبی مرتبط با ایمنی; Anti-PD-1; Autoimmune diabetes; Human immunodeficiency virus; Immune checkpoint inhibitor; Immune-related adverse event;
Keywords: عوارض جانبی مرتبط با ایمنی; Immune-related adverse event; PD1; PD-L1; Complications; Imaging;
Keywords: عوارض جانبی مرتبط با ایمنی; HNSCC; head and neck squamous cell carcinoma; R/M; recurrent and/or metastatic; ICPi; immune checkpoint inhibitor; irAE; immune-related adverse event; Gy; gray; MRC; Medical Research Council; CK; creatinine kinase; U/L; units per Liter; AST; aspartate tra
Keywords: عوارض جانبی مرتبط با ایمنی; Nivolumab; Non-small-cell lung cancer; Immune-related adverse event; Hu paraneoplastic antibody; Neurological toxicity; Dysphasia;
Keywords: عوارض جانبی مرتبط با ایمنی; Immune-related adverse event; Immunotherapy; Nivolumab; Non-small cell lung cancer; Psoriatic arthritis; Programmed cell death-1;
Keywords: عوارض جانبی مرتبط با ایمنی; CTLA-4; cytotoxic T-lymphocyte-associated protein 4; ICI; immune checkpoint inhibitor; irAE; immune-related adverse event; mRSS; modified Rodnan skin score; PD-1; programmed cell death 1; PD-L1; programmed cell death ligand 1; RNAP3; RNA polymerase III;
Keywords: عوارض جانبی مرتبط با ایمنی; IC; immune checkpoint; ICB; immune checkpoint blocker; irAE; immune-related adverse event; NSCLC; non-small cell lung cancer; ORR; overall response rate; OS; overall survival; RCC; renal cell carcinoma; Neoplasms; Aged; Toxicity; Immunotherapy; Medical on
Keywords: عوارض جانبی مرتبط با ایمنی; cancer therapy; chemotherapy; cutaneous reactions; drug hypersensitivity; rash; target drugs; EGFR; epidermal growth factor receptor; EGFRI; epidermal growth factor receptor inhibitor; HFSR; hand-foot skin reaction; IRAE; immune-related adverse event; M
Severe interstitial pneumonia associated with anti-PD-1 immune checkpoint antibody after talc slurry pleurodesis
Keywords: عوارض جانبی مرتبط با ایمنی; SqCC; squamous cell carcinoma; anti-PD-1; anti-programmed death-1; irAE; immune-related adverse event; PS; Eastern Cooperative Oncology Group performance status; CRP; C-reactive protein; LDH; lactate dehydrogenase; CT; computed tomography; VC; vital capac
Nivolumab in routine practice for older patients with advanced or metastatic non-small cell lung cancer
Keywords: عوارض جانبی مرتبط با ایمنی; NSCLC; non-small cell lung cancer; IrAE; immune-related adverse event; PFS; progression-free survival; OS; overall survival; CMI; Charlson's comorbidity index; ECOG; Eastern Cooperative Oncology Group; ADR; adverse drug reaction; SAE; serious adverse even
Recent Developments in Oncology Immunotherapy, Implications for NPs Part 1
Keywords: عوارض جانبی مرتبط با ایمنی; cytotoxic T-lymphocyte antigen 4; immune checkpoint inhibitor; immune-related adverse event; immunotherapy; nurse practitioner; programmed cell death 1; programmed death-ligand 1;
Immune-related bone marrow failure following anti-PD1 therapy
Keywords: عوارض جانبی مرتبط با ایمنی; Emergent adverse event; Immune-related adverse event; Aplastic anaemia; Bone marrow failure; Anti-PD1 therapy;
Polymyositis induced by PD-1 blockade in a patient in hepatitis B remission
Keywords: عوارض جانبی مرتبط با ایمنی; Immune-checkpoint inhibitors; Polymyositis; Immunological memory; Molecular mimicry; HBV; hepatitis B virus; ICI; immune checkpoint inhibitor; ICIM; immune checkpoint inhibitor-induced myopathy; IIM; idiopathic inflammatory myopathy; IRAE; immune-related
Targeting GPNMB with glembatumumab vedotin: Current developments and future opportunities for the treatment of cancer
Keywords: عوارض جانبی مرتبط با ایمنی; AE; Adverse Event; α-MSH; alpha-Melanocyte Stimulating Hormone; ADC; Antibody-Drug Conjugate; ASPS; Alveolar Soft Part Sarcoma; ASPSCR1; Alveolar Soft Part Sarcoma Chromosome Region Candidate 1; BMP-2; Bone Morphogenetic Protein-2; BRK; Breast Tumor Kina
Early Immune-Related Adverse Events and Association with Outcome in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab: AÂ Prospective Cohort Study
Keywords: عوارض جانبی مرتبط با ایمنی; Immune checkpoint inhibitor; Immune-related adverse event; Nivolumab; Non-small cell lung cancer; Programmed cell death ligand 1;
Le diabète fulminant, un effet secondaire grave des anticorps anti-PD1 : à propos de quatre cas survenus en cours de traitement pour mélanome
Keywords: عوارض جانبی مرتبط با ایمنی; Diabète de type 1 fulminant; cétose; anticorps anti-PD-1; effets secondaires; toxicité; pembrolizumab; nivolumab; évènements adverse immuno-dépendants; Fulminant type 1 diabetes; ketosis; anti-PD-1 antibodies; side-effects; toxicity; pembrolizumab;
Ipilimumab in patients with cancer and the management of dermatologic adverse events
Keywords: عوارض جانبی مرتبط با ایمنی; adverse event management; dermatologic; immune-related; ipilimumab; melanoma; pruritus; rash; vitiligo; AE; adverse event; CTLA; cytotoxic T-lymphocyte antigen; GI; gastrointestinal; irAE; immune-related adverse event;